Persistent Nasal Skin Lesions in Pemphigus Patients and the Role of Methotrexate in Treatment: A Case Series Study
Introduction: Nasal involvement might infrequently happen and some lesions may not respond to conventional treatments. Objectives: The current case series report aims to describe the characteristics of 10 confirmed pemphigus vulgaris (PV) and pemphigus foliaceus (PF) patients with nasal skin lesi...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mattioli1885
2025-01-01
|
| Series: | Dermatology Practical & Conceptual |
| Subjects: | |
| Online Access: | https://dpcj.org/index.php/dpc/article/view/4521 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832540732919906304 |
|---|---|
| author | Mohamad Reza Kavyani Maryam Daneshpazhooh Sama Heidari Navid Namakizadeh Esfahani Sarina Ahmadian Arghavan Azizpour Kamran Balighi |
| author_facet | Mohamad Reza Kavyani Maryam Daneshpazhooh Sama Heidari Navid Namakizadeh Esfahani Sarina Ahmadian Arghavan Azizpour Kamran Balighi |
| author_sort | Mohamad Reza Kavyani |
| collection | DOAJ |
| description |
Introduction: Nasal involvement might infrequently happen and some lesions may not respond to conventional treatments.
Objectives: The current case series report aims to describe the characteristics of 10 confirmed pemphigus vulgaris (PV) and pemphigus foliaceus (PF) patients with nasal skin lesions who did not respond to conventional treatment options or relapsed after a while and to evaluate the role of methotrexate in treatment.
Methods: Data regarding patient demographics, disease type and severity, nasal lesion characteristics, and treatment response was obtained from medical records and direct communication with patients between 2019 and 2023.
Results: Eight patients received intravenous rituximab (RTX) and 3 methotrexate. Out of the 8 pemphigus vulgaris (PV) patients who underwent RTX treatment, a total of 18 treatment sessions were carried out. Following RTX therapy, significant improvements in the nasal lesions were observed after 11 (61.1%) sessions, with 8 patients (44.4%) achieving complete resolution within 6 months. Additionally, 3 patients who did not have satisfactory results after RTX treatment, received methotrexate, and all of them experienced complete recovery of their nasal lesions within the same time frame.
Conclusions: All the patients who benefited from methotrexate never experienced complete remission of their nasal lesions before. It seems methotrexate can be an eligible choice for recalcitrant cases.
|
| format | Article |
| id | doaj-art-df193816ffce46768455bc5d962b8f1e |
| institution | Kabale University |
| issn | 2160-9381 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Mattioli1885 |
| record_format | Article |
| series | Dermatology Practical & Conceptual |
| spelling | doaj-art-df193816ffce46768455bc5d962b8f1e2025-02-04T15:41:42ZengMattioli1885Dermatology Practical & Conceptual2160-93812025-01-0115110.5826/dpc.1501a4521Persistent Nasal Skin Lesions in Pemphigus Patients and the Role of Methotrexate in Treatment: A Case Series StudyMohamad Reza Kavyani 0Maryam Daneshpazhooh1Sama Heidari2Navid Namakizadeh Esfahani3Sarina Ahmadian 4Arghavan Azizpour5Kamran Balighi6Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran. 2.Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, IranDepartment of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran. 2.Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, IranDepartment of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran. 2.Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, IranDepartment of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran. 2.Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, IranSchool of Medicine, Isfahan University of Medical Sciences, Isfahan, IranDepartment of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran. 2.Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, IranDepartment of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran. 2.Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran Introduction: Nasal involvement might infrequently happen and some lesions may not respond to conventional treatments. Objectives: The current case series report aims to describe the characteristics of 10 confirmed pemphigus vulgaris (PV) and pemphigus foliaceus (PF) patients with nasal skin lesions who did not respond to conventional treatment options or relapsed after a while and to evaluate the role of methotrexate in treatment. Methods: Data regarding patient demographics, disease type and severity, nasal lesion characteristics, and treatment response was obtained from medical records and direct communication with patients between 2019 and 2023. Results: Eight patients received intravenous rituximab (RTX) and 3 methotrexate. Out of the 8 pemphigus vulgaris (PV) patients who underwent RTX treatment, a total of 18 treatment sessions were carried out. Following RTX therapy, significant improvements in the nasal lesions were observed after 11 (61.1%) sessions, with 8 patients (44.4%) achieving complete resolution within 6 months. Additionally, 3 patients who did not have satisfactory results after RTX treatment, received methotrexate, and all of them experienced complete recovery of their nasal lesions within the same time frame. Conclusions: All the patients who benefited from methotrexate never experienced complete remission of their nasal lesions before. It seems methotrexate can be an eligible choice for recalcitrant cases. https://dpcj.org/index.php/dpc/article/view/4521case series MethotrexateNasal SkinPemphigusPersistentRituximab |
| spellingShingle | Mohamad Reza Kavyani Maryam Daneshpazhooh Sama Heidari Navid Namakizadeh Esfahani Sarina Ahmadian Arghavan Azizpour Kamran Balighi Persistent Nasal Skin Lesions in Pemphigus Patients and the Role of Methotrexate in Treatment: A Case Series Study Dermatology Practical & Conceptual case series Methotrexate Nasal Skin Pemphigus Persistent Rituximab |
| title | Persistent Nasal Skin Lesions in Pemphigus Patients and the Role of Methotrexate in Treatment: A Case Series Study |
| title_full | Persistent Nasal Skin Lesions in Pemphigus Patients and the Role of Methotrexate in Treatment: A Case Series Study |
| title_fullStr | Persistent Nasal Skin Lesions in Pemphigus Patients and the Role of Methotrexate in Treatment: A Case Series Study |
| title_full_unstemmed | Persistent Nasal Skin Lesions in Pemphigus Patients and the Role of Methotrexate in Treatment: A Case Series Study |
| title_short | Persistent Nasal Skin Lesions in Pemphigus Patients and the Role of Methotrexate in Treatment: A Case Series Study |
| title_sort | persistent nasal skin lesions in pemphigus patients and the role of methotrexate in treatment a case series study |
| topic | case series Methotrexate Nasal Skin Pemphigus Persistent Rituximab |
| url | https://dpcj.org/index.php/dpc/article/view/4521 |
| work_keys_str_mv | AT mohamadrezakavyani persistentnasalskinlesionsinpemphiguspatientsandtheroleofmethotrexateintreatmentacaseseriesstudy AT maryamdaneshpazhooh persistentnasalskinlesionsinpemphiguspatientsandtheroleofmethotrexateintreatmentacaseseriesstudy AT samaheidari persistentnasalskinlesionsinpemphiguspatientsandtheroleofmethotrexateintreatmentacaseseriesstudy AT navidnamakizadehesfahani persistentnasalskinlesionsinpemphiguspatientsandtheroleofmethotrexateintreatmentacaseseriesstudy AT sarinaahmadian persistentnasalskinlesionsinpemphiguspatientsandtheroleofmethotrexateintreatmentacaseseriesstudy AT arghavanazizpour persistentnasalskinlesionsinpemphiguspatientsandtheroleofmethotrexateintreatmentacaseseriesstudy AT kamranbalighi persistentnasalskinlesionsinpemphiguspatientsandtheroleofmethotrexateintreatmentacaseseriesstudy |